Correlation Between AVROBIO and Icosavax
Can any of the company-specific risk be diversified away by investing in both AVROBIO and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AVROBIO and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AVROBIO and Icosavax, you can compare the effects of market volatilities on AVROBIO and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AVROBIO with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of AVROBIO and Icosavax.
Diversification Opportunities for AVROBIO and Icosavax
Weak diversification
The 3 months correlation between AVROBIO and Icosavax is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding AVROBIO and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and AVROBIO is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AVROBIO are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of AVROBIO i.e., AVROBIO and Icosavax go up and down completely randomly.
Pair Corralation between AVROBIO and Icosavax
If you would invest 902.00 in Icosavax on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Icosavax or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AVROBIO vs. Icosavax
Performance |
| Timeline |
| AVROBIO |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
AVROBIO and Icosavax Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AVROBIO and Icosavax
The main advantage of trading using opposite AVROBIO and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AVROBIO position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.| AVROBIO vs. Ocean Biomedical | AVROBIO vs. Enveric Biosciences | AVROBIO vs. Elevation Oncology | AVROBIO vs. Zura Bio Limited |
| Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |